Surgical Sutures Market Worth US$6.65 billion by 2030

 The global Surgical Sutures Market, valued at US$4.56 billion in 2024 stood at US$4.84 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$6.65 billion by the end of the period. The demand for surgical sutures is on the rise, driven largely by the increasing frequency of surgical interventions worldwide. This trend is significantly influenced by the aging population, which is more susceptible to chronic conditions such as cardiovascular diseases, diabetes, and orthopedic disorders that often require surgical intervention. Additionally, the rising incidence of trauma and accidental injuries globally contributes to the heightened need for sutures. Advancements in suture technology, including the development of absorbable, antibacterial, and barbed sutures, are crucial in enhancing patient recovery, minimizing post-operative complications, and reducing infection rates. These innovations not only improve surgical outcomes but also contribute to the overall growth of the sutures market by addressing specific clinical needs and improving the efficiency of surgical procedures.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18374832

Browse in-depth TOC on "Surgical Sutures Market"
348 - Tables
52 - Figures
319 - Pages

By product, Suture thread dominates the surgical sutures market due to its essential role in wound closure across various surgical procedures. As the core component of any suturing system, it is integral to traditional open surgeries and minimally invasive techniques. The preeminence of suture thread can be attributed to its remarkable versatility, diverse material options, and continuous advancements in design and functionality. Innovations such as non-absorbable, absorbable, antibacterial-coated, and barbed suture threads have expanded their application spectrum across various surgical disciplines, including cardiovascular, orthopedic, gynecologic, and general surgery. Clinicians increasingly opt for threads characterized by high tensile strength, minimal tissue reactivity, and reliable absorption profiles—attributes that leading manufacturers consistently refine to meet the evolving demands of surgical practice.

By type, Multifilament sutures dominate the surgical sutures market due to their superior handling properties, reliable knot security, and broad application across various surgical specialties. These sutures are constructed from multiple braided or twisted filaments, which give them enhanced flexibility and tensile strength compared to their monofilament counterparts. This makes multifilament sutures particularly well-suited for surgical procedures that demand precise tissue closure, as they can adapt more readily to the contours of the tissue being sutured. The intricate design of multifilament sutures allows for better manipulation during surgical procedures, enabling surgeons to achieve a secure and stable closure. The improved knot-holding capability of these sutures is crucial in maintaining the integrity of the surgical site, reducing the risk of complications that can arise from loosening or failure. In high-pressure clinical environments, where time is often of the essence, the ease of handling that multifilament sutures provide can streamline surgical processes, ultimately contributing to shorter operation times and improved patient outcomes. Their versatility and effectiveness have made multifilament sutures a preferred choice among surgeons in numerous fields, including general surgery, orthopedics, and plastic surgery.

By geography, the surgical sutures market is characterized by five key regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America stands at the forefront of this market, bolstered by its advanced healthcare infrastructure, high surgical throughput, and the presence of leading industry players. The region features a robust network of hospitals, ambulatory surgical centers, and specialty clinics that engage in a wide array of complex surgical procedures—including cardiovascular, orthopedic, and general surgeries—all of which rely heavily on high-performance surgical sutures. Particularly, the US accounts for the largest market share due to its aging demographic, the prevalence of lifestyle-related chronic diseases, and an increasing demand for cosmetic and minimally invasive surgical interventions. Furthermore, North America is a hub for technological innovation, housing major corporations such as Ethicon and Medtronic, which consistently introduce cutting-edge suture materials and methodologies. This includes advancements in antimicrobial and absorbable sutures, which are crucial in improving surgical outcomes and patient safety.

Request Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=18374832

The key players in the global surgical sutures market are Ethicon [Johnson & Johnson Services, Inc.] (US), Medtronic (Ireland), B. Braun SE (Germany), Advanced Medical Solutions Group Plc (UK), Healthium MedTech Limited (India), Boston Scientific Corporation (US) Zimmer Biomet Holdings, Inc. (US), Stryker (US), Smith+Nephew (UK), Conmed Corporation (US), Internacional Farmacéutica S.A. de C.V. (Mexico), Corza Medical (US), DemeTECH Corporation (US), Unisur Lifecare Pvt. Ltd (India), Assut Europe (Italy), RESORBA Medical GmbH (Germany), KATSAN Katgüt Sanayi ve Tic. A.S. (Turkey), Sutumed Corp. (US), Mellon Medical (Netherlands), Futura Surgicare Pvt. Ltd. (India), GMD Group (Turkey), Lotus Surgicals Pvt Ltd (India), BioSintex (Romania), Meril Life Sciences Pvt. Ltd. (India), and Aqmen Medtech (India).